Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewCell biologyNephrology Open Access | 10.1172/jci.insight.198555

SMOC2 promotes partial epithelial-to-mesenchymal transition and maladaptive repair in renal tubular epithelial cells

Schrodinger Cenatus,1 Peng Gao,1 Nathalie Henley,1 Caroline Lamarche,1 Xue-Song Liu,2 Frédérick A. Mallette,1 Jonatan Barrera-Chimal,1 and Casimiro Gerarduzzi1

1Maisonneuve-Rosemont Hospital Research Centre, Montréal, Canada

2School of Life Science and Technology, ShanghaiTech University, Shanghai, China

Find articles by Cenatus, S. in: PubMed | Google Scholar

1Maisonneuve-Rosemont Hospital Research Centre, Montréal, Canada

2School of Life Science and Technology, ShanghaiTech University, Shanghai, China

Find articles by Gao, P. in: PubMed | Google Scholar

1Maisonneuve-Rosemont Hospital Research Centre, Montréal, Canada

2School of Life Science and Technology, ShanghaiTech University, Shanghai, China

Find articles by Henley, N. in: PubMed | Google Scholar

1Maisonneuve-Rosemont Hospital Research Centre, Montréal, Canada

2School of Life Science and Technology, ShanghaiTech University, Shanghai, China

Find articles by Lamarche, C. in: PubMed | Google Scholar

1Maisonneuve-Rosemont Hospital Research Centre, Montréal, Canada

2School of Life Science and Technology, ShanghaiTech University, Shanghai, China

Find articles by Liu, X. in: PubMed | Google Scholar

1Maisonneuve-Rosemont Hospital Research Centre, Montréal, Canada

2School of Life Science and Technology, ShanghaiTech University, Shanghai, China

Find articles by Mallette, F. in: PubMed | Google Scholar |

1Maisonneuve-Rosemont Hospital Research Centre, Montréal, Canada

2School of Life Science and Technology, ShanghaiTech University, Shanghai, China

Find articles by Barrera-Chimal, J. in: PubMed | Google Scholar

1Maisonneuve-Rosemont Hospital Research Centre, Montréal, Canada

2School of Life Science and Technology, ShanghaiTech University, Shanghai, China

Find articles by Gerarduzzi, C. in: PubMed | Google Scholar

Published August 12, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.198555.
Copyright © 2026, Cenatus et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published August 12, 2026 - Version history
View PDF
Abstract

Chronic kidney disease is a global health concern characterized by maladaptive repair processes leading to kidney fibrosis. Following injury, early alterations in the extracellular matrix precede the development of kidney fibrosis and represent potential therapeutic targets to improve kidney repair. In this context, studies from our laboratory and others have shown that the matricellular protein SMOC2 can be targeted to decrease inflammation and tubulointerstitial fibrosis following kidney injury. The tubular epithelial cells (TECs), which are abundant and particularly susceptible to injury, play a central role in maladaptive repair; however, whether SMOC2 affects their functionality after kidney injury has not been explored. In this study, we show that SMOC2 localizes to the basement membrane of injured TECs across three murine models of kidney injury. Our in vitro studies demonstrate that SMOC2 induces a partial epithelial-to-mesenchymal (EMT) transition of TECs. We further demonstrate that its extracellular calcium-binding domain mediates binding to the decellularized extracellular matrix and mediates most of its effects on TECs. Mechanistically, SMOC2 promotes partial EMT effects through an integrin-dependent pathway. Together, these findings provide new mechanistic insight into how SMOC2 drives maladaptive repair by modulating TEC behavior and identify its calcium-binding domain as a key functional mediator.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View

Version history
  • Version 1 (August 12, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts